Cellectis to Hold Fourth Quarter 2020 Earnings Call on Friday, March 5, 2021 at 8:00AM EST

    NEXT STORY
    Endeavour Increases 2021 Production Guidance by 50% to 1.4 – 1.5 Million Ounces
    PREV STORY
    Caladrius Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Loxo Oncology Announces the Closing of its Follow-On Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

    STAMFORD, Conn., May 17, 2016 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical ...

    author_avatar
    NASDAQ Market News

    Central Venous Catheter Market To Witness Impressive Expansion, Reflecting A 5.1% CAGR During 2016-2026

    Global Central Venous Catheter Market Anticipated to be Valued at US$ 1,108.4 Mn by ...

    author_avatar
    NASDAQ Market News

    Publishing of Orion Corporation’s Interim Report for January-March 2018 on 24 April 2018

    author_avatar
    NASDAQ Market News